Harvest Portfolios Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.37M Buy
84,300
+11,500
+16% +$306K 0.04% 173
2025
Q4
$1.81M Hold
72,800
0.03% 177
2025
Q3
$1.85M Buy
72,800
+2,200
+3% +$54.3K 0.03% 170
2025
Q2
$1.71M Hold
70,600
0.04% 160
2025
Q1
$1.79M Sell
70,600
-300
-0.4% -$7.85K 0.05% 138
2024
Q4
$1.88M Hold
70,900
0.06% 115
2024
Q3
$2.05M Buy
70,900
+8,200
+13% +$239K 0.07% 121
2024
Q2
$1.75M Sell
62,700
-8,100
-11% -$223K 0.07% 119
2024
Q1
$1.96M Buy
70,800
+12,000
+20% +$333K 0.08% 121
2023
Q4
$1.69M Buy
58,800
+1,700
+3% +$51.4K 0.07% 123
2023
Q3
$1.89M Sell
57,100
-1,297,442
-96% -$45.9M 0.09% 116
2023
Q2
$49.7M Buy
1,354,542
+185,400
+16% +$7.22M 2.28% 16
2023
Q1
$47.7M Buy
1,169,142
+251,784
+27% +$10.9M 2.34% 17
2022
Q4
$47M Buy
+917,358
New +$44M 2.7% 12

Other funds holding PFE

Harvest Portfolios Group's PFE Position: Q1 2026 in Review

Harvest Portfolios Group increased its Pfizer (PFE) stake by 16% in Q1 2026, buying an estimated $306K and bringing the position to 84,300 shares worth $2.37M. The position accounts for 0.04% of the portfolio, ranked #173.

Harvest Portfolios Group first reported a position in PFE in Q4 2022 and has held it in 14 quarters since. The position peaked at $49.7M in Q2 2023. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Harvest Portfolios Group held 84,300 shares of Pfizer worth $2.37M as of Q1 2026.
  • Harvest Portfolios Group bought 11,500 Pfizer shares in Q1 2026, an estimated $306K.
  • Pfizer made up 0.04% of Harvest Portfolios Group's portfolio in Q1 2026, its #173 holding.
  • Harvest Portfolios Group first reported a position in Pfizer in Q4 2022 and has held it in 14 quarters since.
  • Harvest Portfolios Group's Pfizer position peaked at $49.7M in Q2 2023.
  • 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Harvest Portfolios Group's 13F filing for Q1 2026, filed 14 May 2026.